COT Meeting: 5th May 2020
On this page
Skip the menu of subheadings on this page.Meeting Agenda
1. Apologies for absence
2. Draft minutes of March meeting TOX/MIN/2020/02
3. Matters Arising
4. CBD - Draft COT position paper, TOX/2020/22
5. Potential risks from use of topically applied CBD-containing cosmetic products TOX/2020/23
6. Scoping paper: alternatives to conventional plastics for food & drinks packaging TOX/2020/24
7. Toxicological interactions between xenobiotics and the human microbiota -Second draft statement TOX/2020/25
8. Draft revisions to COT Terms of Reference and Code of Practice TOX/2020/26
9. WRAP study on potatoes and acrylamide (reserved) TOX/2020/27
10. Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes).
Updated risk assessments for exposure of users to propylene glycol (PG) and glycerol from inhalation of E(N)NDS aerosols. TOX/2020/29
11. Update on the work of other advisory committees TOX/2020/28
12. Any other business:
New ways of working
COT website
Next meeting of the Committee at 10.00am on Tuesday 7th July 2020 via Microsoft Teams
Media discussed during the meeting
Please see information on reserved items on the Procedure for holding COT meetings in open session page
Final minutes of the meeting of the Committee held on 10th March 2020
Final minutes of the meeting of the Committee held on 10th March at Manchester Conference Centre, Weston Building, Sackville Street, Manchester, Greater Manchester.
Minutes for an additional COT meeting on the EFSA draft opinion on PFAS currently out for public consultation on 9th April 2020
An additional COT meeting was held via Microsoft Teams to discuss the draft EFSA opinion on PFAS as a key study was not published in time for the March meeting. Paper TOX/2020/18 circulated in March was the basis for the discussion.
Draft minutes for the COT Meeting: 5th May 2020
Draft minutes from the COT meeting on 5th May 2020 via Microsoft Teams
TOX 2020 - 22
Interim position paper on the potential risk of CBD in CBD products
TOX 2020 - 23
Potential risks from use of topically applied CBD-containing cosmetic products
TOX 2020 - 24
Scoping paper: alternatives to conventional plastics for food & drinks packaging
TOX 2020 - 25
Toxicological interactions between xenobiotics and the human microbiota - second draft statement
TOX 2020 - 26
Revised COT Terms of Reference and Code of Practice
TOX 2020 - 28
Update on the work of the other Scientific Advisory Committees
TOX 2020 - 29
Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Updated risk assessments for exposure of users to propylene glycol (PG) and glycerol from inhalation of E(N)NDS aerosols.
Annex A of TOX 2020 - 29
Annex A of potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Updated risk assessments for exposure of users to propylene glycol (PG) and glycerol from inhalation of E(N)NDS aerosols.
Annex B of TOX 2020 - 29
Annex B of potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Updated risk assessments for exposure of users to propylene glycol (PG) and glycerol from inhalation of E(N)NDS aerosols.
Addendum to TOX 2020 - 29
Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Non-technical summary for E(N)NDS statement
COT Meeting: 5th May 2020 Agenda
Meeting of the Committee at 10:00, 5th May 2020 via Microsoft Teams
Final minutes of the meeting of the Committee on 5th May 2020
The final minutes of the meeting of the Committee held on Tuesday 5th May 2020 via Microsoft Teams
Additional item to May Minutes
Reserved minutes for Item 9: WRAP study on potatoes and acrylamide (reserved) (TOX/2020/27)